WELCOME, HACKATHON PARTICIPANTS!
NEXT STEPS
Complete the Attendance Confirmation Form sent to participants with a provisional spot.
We kindly request that all registered participants complete this form, whether or not you plan to attend.
If we do not receive your form by Saturday, February 21st at 12:00 PM EST, your provisional spot will be released, and we will assume you are not participating in the event.
Those who have received a provisional spot can find the Attendance Confirmation Form link in the email with the subject “Thank you for registering for HackRare 2026!”.
Join our event Slack.
Slack will serve as our central hub for updates, schedule details, and participant communication throughout the event
Find your hackathon team.
The HackRare 2026 Teams Spreadsheet is now available and includes tabs for current teams as well as participants who are still looking for a team. Your status as a provisional vs. confirmed participant can be viewed here.
When you have found a team, or if you would like to update your team composition or change your assigned track, please complete the Team Change Form. We accept teams of 2-5 participants. Individual teams are not permitted.
Participants who do not have a team by Friday, February 27, 2026 at 12:00 PM EST are still fully eligible to participate. The organizing team will assign teams based on track interest.
Familiarize yourself with our event schedule.
The venue will be open for the full duration of the event from 9:00 AM on Saturday to 7:00 PM on Sunday. Participants are welcome to use the workspace for overnight rest. If you plan to stay overnight, please bring a sleeping bag, toiletries, and any personal essentials.
We will be hosting two public virtual webinars with our partnering patient organizations ahead of the event on Saturday, February 21, 2026 at 3 PM and 6 PM EST.
These webinars allow you to hear directly from individuals affected by rare diseases, learn about real-world challenges that may shape your project, and ask questions to deepen your understanding of the rare disease community.
